Related Experiment Video
Updated: Jan 3, 2026

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
Published on: June 16, 2022
HMGB3 small interfere RNA suppresses mammosphere formation of MDA-MB-231 cells by down-regulating expression of HIF1α
1Department of Health Check-Up Center, Jinshan Hospital, Fudan University, Shanghai, China. liuzheef@sina.com.
Objective:
Breast cancer has been proven as the most common malignancy influencing the health of females. This research aimed to clarify the effects of high-mobility group box 3 (HMGB3)-small interfere RNA (HMGB3-siRNA) on the proliferation of breast cancer cells.
Materials And Methods:
HMGB3-mimic and HMGB3-siRNA lentiviral vectors were structured. The above lentiviral vectors were then transfected into normal breast cells (MCF10A) and breast cancer cells (MDA-MB-231). Cell counting kit-8 (CCK-8) analysis was employed to assess proliferative viabilities of cells. The formation of the mammosphere in breast cancer cells was examined using mammosphere-forming assay. The mRNA expression of Nanog, Sox2, and OCT-4 genes was evaluated using quantitative real time-PCR (qRT-PCR). CD44 positive/CD24 negative (CD44+/CD24-) cell levels were evaluated using flow cytometry assay. The correlation between HMGB3 and hypoxia-inducible factor 1α (HIF1α) was analyzed using Linear-Regression analysis. The interaction between HMGB3 and HIF1α expression was determined using the Dual-Luciferase assay.
Results:
HMGB3 expression was remarkably enhanced in breast cancer cells compared to that in normal cells (p<0.05). HMGB3-siRNA significantly decreased the proliferative activity and remarkably suppressed the mammosphere formation compared to that in single MDA-MB-231 cells (p<0.05). HMGB3-siRNA remarkably reduced Nanog, SOX2, and OCT-4 and significantly enhanced CD44+/CD24- cells compared to single MDA-MB-231 cells (p<0.05). HMGB3-siRNA significantly weakened the expression of HIF1α in MDA-MB-231 cells compared to single MDA-MB-231 cells (p<0.05). HMGB3 was positively correlated with HIF1α expression (p<0.05). There was an interaction between HMGB expression and HIF1α expression.
Conclusions:
HMGB3 small interfering RNA suppressed the formation of mammosphere in MDA-MB-231 cells by downregulating the expression of HIF1α.
Insights
High-mobility group box 3 (HMGB3) small interfering RNA (siRNA) inhibits breast cancer cell proliferation. HMGB3-siRNA suppresses mammosphere formation by downregulating hypoxia-inducible factor 1α (HIF1α) expression.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Breast cancer is a prevalent malignancy affecting women globally.
- High-mobility group box 3 (HMGB3) is implicated in various cancers.
- Understanding HMGB3's role in breast cancer proliferation is crucial for therapeutic development.
Purpose of the Study:
- To investigate the effect of HMGB3-siRNA on breast cancer cell proliferation.
- To elucidate the underlying molecular mechanisms involving HMGB3, stem cell markers, and HIF1α.
Main Methods:
- HMGB3-siRNA lentiviral vectors were transfected into breast cancer cells (MDA-MB-231).
- Cell proliferation was assessed using CCK-8 assays.
- Mammosphere formation, stem cell marker expression (Nanog, Sox2, OCT-4), and CD44+/CD24- cell populations were evaluated.
- The correlation and interaction between HMGB3 and HIF1α were analyzed.
Main Results:
- HMGB3 expression was significantly elevated in breast cancer cells.
- HMGB3-siRNA treatment reduced cell proliferation and mammosphere formation.
- HMGB3-siRNA downregulated Nanog, Sox2, and OCT-4, while increasing CD44+/CD24- cells.
- HMGB3-siRNA significantly decreased HIF1α expression, with a positive correlation observed between HMGB3 and HIF1α.
Conclusions:
- HMGB3 small interfering RNA effectively suppresses breast cancer cell proliferation and mammosphere formation.
- The observed effects are mediated through the downregulation of hypoxia-inducible factor 1α (HIF1α).
- HMGB3 may represent a potential therapeutic target in breast cancer treatment.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
11:44Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...